secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K
Filed at:   2023-07-13T23:59:59+00:00
Accession:  0001493152-23-024463
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 1.01, 2.03, 3.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Bioscience Enters Acquisition Closing Agreements, Obtains $100K Loan, and Faces Nasdaq Delisting Notice
--------------------------------------------------------------------------------

- Entered closing agreements to complete acquisition of Wisconsin Fertility Institute and Fertility Labs of Wisconsin by July 31, 2023, paying $10K and $40K in fees.
- Obtained $100K loan from related-party JAG Multi Investments LLC, with a warrant for 150,000 shares at $0.189, and extended repayment of prior $500K loans to Sept 30, 2023.
- Received Nasdaq delisting notice on July 11, 2023 for failure to meet minimum bid price rule; plans to submit compliance plan to the Hearing Panel.
- Amended prior asset purchase agreements to adjust stock consideration for future stock splits or combinations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223024463/0001493152-23-024463-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223024463/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-024463

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer